Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulopenem vs Ertapenem for Complicated Urinary Tract Infections (SURE-2)
NCT03357614Phase 3Completed
- Sponsor
- Iterum Therapeutics plc
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of sulopenem in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Iterum Therapeutics plc. Started Sep 2018; status: completed.
02
Drugs
sulopenem
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT03357614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357614.